Of the latter, 39 were part of a cohort-specific fingerprint including RPS6KA2, CADM4, and NF1 for GBM as well as ATM, BAX, RB1, and RASSF5 for DLBCL (Fig. 6B). This evidence concerns the gene RPS6KA2 and glioblastoma.